Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Carlos Cordon-Cardo, Richard Hockett, Jasmine Gruia-Gray


Agilent Technologies said this week that it has awarded its Agilent Thought Leader Award to Carlos Cordon-Cardo, a molecular pathologist at Mount Sinai Hospital

The award will support his teams work using genomics and proteomics to characterize tumor-initiating cells with stem-cell-like properties taken from patients with various types of cancer with the aim of better understanding their ability to resist drug treatment and to metastasize.

Biodesix said this week it has added Richard Hockett and Jasmine Gruia-Gray to its leadership team.

Hockett will serve as chief medical officer, and will oversee regulatory, medical, and clinical strategy. He formerly was CMO at CombiMatrix and before that was at Affymetrix, and he developed Eli Lilly's pharmacogenomic program.

Gruia-Gray was appointed VP of strategic marketing. She previously held marketing leadership jobs at Affymetrix and Thermo Fisher Scientific, and she helped develop the proteomics portfolio at GE Healthcare. She also spent five years as a post-doctoral fellow at the National Institute of Diabetes and Digestive and Kidney Diseases.